K. Kolb

[Pharmacokinetics and metabolite spectrum of glisoxepide in humans].

W. Mützel, U. Speck, K. Kolb, 1974, Arzneimittel-Forschung.

[2-Benzolsulfonamido-5(beta-methoxy-ethoxy)-pyrimidine (Glycodiazine). II. Metabolism of 2-benzolsulfonamido-5(beta-hydroxy-ethoxy)-pyrimidine, a blood sugar reducing metabolite of glycodiazine in man].

K. Kolb, E. Gerhards, 1965, Arzneimittel-Forschung.

The impact of hunting disturbance on a protected species, the Whooper Swan Cygnus cygnus at Lake Constance

P. Frenzel, K. Kolb, M. Schneider-Jacoby, 1991 .

ABSORPTION, DISTRIBUTION AND ELIMINATION OF LABELED DIMETHYL SULFOXIDE IN MAN AND ANIMALS

K H Kolb, G Jaenicke, M Kramer, 1967, Annals of the New York Academy of Sciences.

Über 2-Benzolsulfonylamino-5 (β-methoxy-äthoxy)-pyrimidin (Glycodiazin). V8

K. Kolb, P. Schulze, E. Gerhards, 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[On metabolism of 17-beta-acetoxy-1-methyl-delta-1-5-alpha-androstenone-(3) (methenolone acetate) in man. II. Isolation and identification of 3-alpha-hydroxy-1-methylene-5-alpha-androstanone-(17) and other metabolites and on mechanism of ring-A-reduction].

K. Kolb, P. Schulze, E. Gerhards, 1965, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

ABSORPTION, DISTRIBUTION AND ELIMINATION OF LABELED DIMETHYL SULFOXIDE IN MAN AND ANIMALS

M. Kramer, K. Kolb, P. Schulze, 1967 .

[The behavior of 35S tagged dimethyl sulfoxide in the human and the animal organism].

G. Raspé, M. Kramer, K. Kolb, 1965, Arzneimittel-Forschung.